Put Warnings About Liver Damage With Hep C Meds Into Perspective
April 2017
You'll hear about a link between hepatitis C meds and liver damage...especially in patients who also have hepatitis B.
Health Canada is warning about the risk of hepatitis B reactivation with newer hep C meds...Epclusa, Harvoni, Zepatier, etc.
And a recent report from Institute for Safe Medication Practices warns about rare cases of liver injury and failure tied to these meds.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive